CLINICAL_TRIALS
trial_result
· 2020-02-10
Clinical Trial Update: Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease [Phase 2]
Summary
Phase 2 clinical trial update of lenalidomide in chronic lymphocytic leukemia patients with residual disease has completed results and posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-02-10